To elucidate factors underlying the increased risk of developing Alzheimer's disease (AD) in older individuals, the prefrontal cortices of younger (58-79 years) and of older (over 80 years) AD patients were examined by silver impregnation, TUNEL assay and immunohistochemistry for hyperphosphorylated tau, LDU and two growth factors (BDNF, NGF). Quantitative data were compared with those of agematched controls. TUNEL-positive cells were mainly located in superficial cortical layers of younger and in deeper layers of older AD patients. Their density was more than 5 times higher in older AD than in younger AD (p~.05), but apoptotic cell morphology was rarely seen. Significantly more neuronal somas were contacted by degenerating fibers both in younger and older AD cortices. Density of tauimmunoreactive cells, which were virtually absent in controls, was twice as high in older AD patients as in younger AD individuals (p~.05). In younger AD, TUNEL positive cells generally lacked tau immunoreaction, whereas in older AD, most cells were double-labeled for hyperphosphorylated tau and TUNEL (p~.05). Numerical density of BDNF-immunoreactive cells was significantly reduced by 20% in older AD patients, compared to both control individuals and younger AD patients, whereas density of NGF-positive cells was the same in all patient groups examined. The distinct differences between younger and older AD patients suggest a faster progression of AD in older patients.
Increasing evidence suggests that activation of apoptotic mechanisms plays a key role in cell death in AD. Apoptosis, a specific form of gene-directed programmed cell death, removes excess, damaged, aged and harmful cells (8) (9) (10) (11) . Triggered by numerous stimuli, e.g. DNA damage, oxidative stress, toxins and withdrawal ofneurotrophic support, an apoptotic program is carried out leading to the eventual demise of the cell. Caspases (cysteine-containing aspartatespecific proteases) and their substrates have been found to play a pivotal role in the execution of apoptosis. Activated caspase-3, the major effector in mammalian neuronal apoptosis, cleaves its target proteins, resulting in the typical features of apoptotic cell death, i.e. cell shrinkage, membrane blebbing, chromatin condensation and nuclear fragmentation (12) (13) . Caspases are activated in AD, amyloid beta protein has been shown to be involved in caspase activation (14) , and there is indication that caspases playa major role in tau filament formation (7) .
DNA fragmentation can be detected by the Terminal deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL) method, which is routinely used to identifyapoptotic cells in histological sections (9) . TUNEL reaction is markedly increased in the AD brain (8) . Although not all TUNELpositive cells are necessarily undergoing apoptotic cell death (11, [15] [16] , it is generally accepted that the rise in TUNEL-positive cells is indicative of a proapoptotic environment resulting in increased vulnerability of neurons in AD (17) .
It has been suggested that neurodegeneration in AD is linked to a lack of trophic support. Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), two members of the neurotrophin gene family, are the most likely candidates involved in neuronal cell death inAD (18) (19) (20) (21) .
Aging is the biggest risk factor for the development ofAD, although the underlying basis is poorly defined (1, 22) . Beyond the age of65, the risk of AD increases exponentially, doubling every five years (23) (24) . Morphological studies on SP,NFT and neuronal densities in very old AD patients indicate that the regional vulnerability to neurodegeneration changes substantially after 90 years of age (25) (26) .
In order to substantiate this assumption and to detect possible differences in the histopathology between very old (over 80 years) and younger (58-79 years) AD patients, we examined the brains of these two age groups by standard neuropathological techniques, including Nissl stain, Bielschowski's silver stain and Guillery's silver impregnation for degenerating nerve fibers (27) . In addition, the percentage of TUNEL-positive cells and the proportion of cells immunoreactive for hyperphosphorylated tau and LDH were quantified. In order to further characterize growth factor involvement, the density of BDNF-and NGFexpressing cells was determined in both age groups and compared with age-matched control patients.
MATERIALS AND METHODS

Tissue samples
The brains were obtained from a total of 29 autopsy cases with prior informed consent of a close relative and with full approval ofthe ethical committees ofGuangzhou hospital authorities, of Taishou hospital authorities and of the Chinese University of Hong Kong. All studies were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Sixteen of the specimens were from individuals with clinically and pathologically diagnosed senile dementia of the Alzheimer's type lasting for at least three years; five of them were less than 80 years old (young AD, three males, two females; age range 58-72 years, mean± SD: 65.4± 5.7) and eleven were 80 years and above (old AD: three males, eight females; age range 82-104 years, mean ± SD: 92.0 ± 5.9). Thirteen specimens were from individuals, matched for age, gender and postmortem delay, who had no history of neurological diseases (young control: n=6, four males, two females; age range 60-79 years, mean ± SD: age 68.8 ± 7.6; old control: n=7, two males, five females; age range 81-93 years, mean ± SD: 86.1 ± 5.0). Drug history was recorded for all patients, who had only received antibiotic treatment, but no psychopharmacological medication. AD was clinically diagnosed according to the "National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association" (NINCDS-ADRA) criteria and the "Diagnostic and Statistical Manual of Mental Disorders", Fourth Edition, (DSM-IV-R) criteria. Younger AD patients had Mini Mental State Examination (MMSE) scores (28) between 12 and 17; in the group of older AD patients, MMSE scores were below 12, going down to 9-10 in the oldest patients. The average score of the normal control individuals (both young and old) was 22. The duration of the illness was between 7 and 10 years in the group of younger AD patients and 5-9 years in older AD patients.
Whole brains were removed with an average postmortem delay of six hours, and tissue samples of the anterior prefrontal cortex (Brodmann's area 10), occipital cortex (area 17), entorhinal cortex (area 28) and hippocampal formation were dissected. Specimens were fixed overnight in 4% paraformaldehyde in phosphate-buffered saline (PBS; pH 7.4), dehydrated in graded ethanol, cleared with xylene and embedded in paraffin. Serial sections were cut in the coronal plane, 90°p erpendicular to the surface to avoid sectioning artifacts. Two sets of slides were obtained for each individual, one of a thickness of 6 11m and one 15 11m thick. All cases underwent a standardized post-mortem neuropathological assessment of AD using established criteria including Braak staging (29) . Four brain regions were examined: prefrontal (area 10), occipital (area 17), entorhinal (area 28) and hippocampal cortices. Diagnosis was confirmed by the characteristic presence of amyloid plaques, neurofibrillary tangles (NFT) and neuronal degeneration. In addition, the presence of~-amyloid in the plaques was ascertained by immunohistochemistry using the rabbit polyclonal Anti-Amyloid Peptide~, Cleavage site 42 (A~42), antibody (AI976, Sigma, St. Louis, MU) (30) . All AD cases had neocortical NFT with involvement of both isocortical association areas and additional involvement of primary cortical (area 17) areas (Braak stage V-VI). In control patients, deposition ofNFT was negligible in the entorhinal cortex as well as the hippocampus and absent in the neocortex (Braak stage :S II). To exclude dementia with Lewy bodies, all brain specimens were scrutinized for Lewy bodies, and only cases devoid of these were included in the study.
Immunohistochemistry
All steps were carried out at room temperature unless stated otherwise. Paraffin sections were mounted on 3aminopropyl triethoxysilane (no. A3648, TESPA, Sigma, St. Louis, MO)-coated glass slides and dried overnight, dewaxed, rehydrated and pretreated with 0.1% TritonX and 0.05% Tween20 in 0.01 M PBS (10 min) followed by two rinses (5 min each) of 0.01 M PBS supplemented with 0.05% Tween20 (PBST) and one rinse of 0.01 M PBS (5 min). The endogenous peroxidase activity was blocked with 3% hydrogen peroxide in absolute methanol for 40 min, followed by two rinses ofPBST and one rinse of PBS (5 min each). To suppress non-specific binding, sections were then incubated for 30 min in normal rabbit or goat serum (1.5% diluted in PBST), depending on the species origin of the secondary antibody. Thereafter, sections were incubated overnight with one of the following primary polyclonal antibodies: 1) rabbit anti-caspase-3 (no. 9662, Cell Signaling Technology Inc., Beverly, MA), detecting endogenous levels of full-length caspase-3 (35 kDa) and the large fragment of caspase-3 resulting from cleavage (17 kDa); 2) rabbit anti-cleaved caspase-3 (AspI75) antibody (no. 9661, Cell Signaling Technology Inc., Beverly, MA), detecting only activated caspase-3, i.e. the large fragment of caspase-3 resulting from cleavage (17 kDa); 3) rabbit anti-tau, isoform 1 phosphorylated at serine 199 [pSI99] (no. 44-734G, Biosource, Camarillo, CA); 4) goat anti-lactate dehydrogenase (LDH) A (sc-27230, Santa Cruz Biotechnology, Santa Cruz, CA); 5) rabbit anti-brain-derived neurotrophic factor (BDNF) (ABl534SP, Chemicon, Temecula, CA); 6) rabbit antinerve growth factor-beta (NGF) (AB1526SP, Chemicon, Temecula, CA). Primary antibodies were diluted in PBST (1:500). The sections were then washed with two rinses of PBST and one rinse of PBS (5 min each). Subsequently, sections were incubated for 1 h with rabbit anti-goat IgG or goat anti-rabbit IgG biotinylated secondary antibodies (Zymed Laboratories, San Francisco, CA), diluted in PBST (1:200). Thereafter, sections were washed twice with PBST and once with PBS (5 min each), incubated with horseradish peroxidase (HRP)-conjugated Streptavidin (Zymed Laboratories, San Francisco, CA) (1:200) for 1 h and were again washed twice with PBST and once with PBS (5 min each). The immunohistological staining signal was visualized by incubating the sections in 0.05% of the substrate 3'3'-diaminobenzidine tetrahydrochloride (DAB) in PBS containing 0.01% hydrogen peroxide. All stainings included negative controls with omission of the primary antibody, which did not show any immunoreaction. The sections were dehydrated, cleared and mounted with Permount" (Fisher Scientific, Hampton, VA). Additional sections were stained with routine methods, including H&E, Nissl stain and Bielschowsky silver impregnation for staining of nerve fibers, neurofibrillary tangles and senile plaques as well as for tangle staging (29, 31) .
TUNELstain
Apoptosis-related DNA strand breaks were endlabeled with dUTP by using terminal deoxynucleotidyl transferase (TdT) from a commercial kit (ApopTag® Peroxidase In Situ Apoptosis Detection Kit, S7100, Chemicon, Temecula, CA) according to the manufacturer's recommendations. Sections were dewaxed, rehydrated and predigested with Proteinase K (10 ug/ml) (P6556, Sigma, St. Louis, MU) for 10 min. Slides were then washed twice with PBST and once with PBS (5 min each). Thereafter, endogenous peroxidase activity was blocked by 3% hydrogen peroxide in absolute methanol (30-45 min), followed by 2 rinses of PBST and 1 rinse of PBS (5 min each). Then equilibration buffer containing dUTP-digoxigenin (supplied with the kit) was applied to the sections (I hour, 4°C). Subsequently, TdT, diluted I: 3 in reaction buffer, was added (1 h, 37°C in a humidified chamber), and enzyme reaction was stopped by dipping the slides in the stop/wash buffer supplied with the kit (15 min). Without washing, anti-digoxigenin conjugated with peroxidase was added to the sections and incubated for 60 min in a humidified chamber. The signals were visualized by incubating the sections in 0.05% DAB in PBS containing 0.01% hydrogen peroxide. Negative controls in which TdT was substituted by reaction buffer did not show any reaction product. The sections were then dehydrated, cleared and mounted with Permount" (Fisher Scientific, Hampton, VA).
In order to visualize hyperphosphorylated tau in TUNEL-positive cells, selected sections were used for double staining. These sections first underwent TUNEL staining as described above and were subsequently immunolabeled with the anti-tau antibody. Brown cytoplasmic label represented immunoreaction for hyperphosphorylated tau, whereas brown reaction product in the nucleus was indicative of positive TUNEL stain.
In order to colocalize hyperphosphorylated tau and caspase 3 expression, a different double-staining protocol was applied. Sections were first immunolabeled using the anti-tau antibody as described above, but DAB reaction was enhanced by nickel. Nickel DAB solution (Vector: Peroxidase Substrate Kit DAB, SK-4100, Vector Laboratories, Inc, Burlingame, CA9401O) was prepared according to the manufacturer's instructions. Thereafter, caspase 3 immunoreaction was detected according to the same protocol, but without nickel enhancement. Immunoreaction for hyperphosphorylated tau appeared dark grey-violet, whereas caspase 3 label was brownish in color.
Guillery 50 methodfor degenerating nerve fibers
Guillery's modification of Nauta's silver stain was employed for detecting degenerating nerve fibers in the samples (27) . Briefly, sections were de-waxed, rehydrated, washed in distilled water (3 times 5 min), incubated for 6 h in 2.8% ammonium hydroxide (dissolved in 50% .ethanol) and washed in distilled water (3 times, 5 min). Next, sections were placed in a mixture of 1.5% silver nitrate and 5% white pyridine for 24 h in the dark at room temperature. Without further washing, slides were placed for 3 mil) in preheated (45°C) working ammoniacal silver nitrate solution (3% silver nitrate, 30% ethanol, 1.5% ammonium hydroxide and 0.1% sodium hydroxide). Again, without rinsing, slides were placed for 1 min in a reducing solution (0.04% citric acid, 0 .4% unbuffered formalin and 9% ethanol), rinsed in distilled water (3 times, 5 min) and fixed in 1% aqueous sodium thiosulphate solution. Slides were washed in running tap water (10 min), dehydrated, cleared and mounted with Permount" (Fisher Scientific, Hampton, VA)
Statistics
For qualitative and quantitative evaluation, sections were observed under a photomicroscope (Axioplan 2 Photomicroscope, Zeiss, Germany). The numbers of TUNEL-positive nuclei and of cells immunoreactive for hyperphosphorylated tau, LDH, BDNF and NGF were counted in 30 randomly selected 700 llm 2 fields of control and AD patients. 4-5 sections per individual were evaluated. Cells contacted by degenerating nerve fibers were counted in sections silver-impregnated according to Guillery et al. (27) , and their number was determined as a percentage of all cells found in the respective fields. In sections double-stained for TUNEL and hyperphosphorylated tau, all cells immunoreactive for hyperphosphorylated tau and all cells double-stained for TUNEL and hyperphosphorylated tau were counted in the respective fields, and the number of double-stained cells was calculated as a percentage of the total number of tau-positive cells. All measurements were expressed as means ± SEM. For statistical comparison, the unpaired Student's t-test was used. The Bonferroni correction for multiple-comparison was applied, and a p value below 0.05 was considered significant.
RESULTS
Histopathology
No pathological changes were observed in Nissl-stained sections of the prefrontal cortex of younger control patients. The cortex of older control individuals showed rare NFTs. In contrast, in the cortex of younger AD patients, numerous neuritic plaques and NFTs were detected, and neuronal density was markedly reduced compared to control cortices. Morphological signs of apoptosis, e.g. nuclear condensation, were only occasionally seen. The prefrontal cortex of older AD patients was packed with neuritic plaques and NFTs, their density being even higher than that of younger AD patients. Sporadically, nuclear condensation indicative of apoptotic cell death was also detected. Correspondingly, neuronal density in the cortex of older AD patients was further decreased and was lower than in younger AD patients, indicating more advanced cortical atrophy.
TUNELstain
The TUNEL assay revealed extensive DNA fragmentation in the prefrontal cortex of younger (58-79 year-old) AD patients, which was mainly observed in the superficial layers (II-IV), whereas fewer cells with TUNEL label were found in the deeper cortical layers (V, VI). In contrast, the prefrontal cortex of younger and older (above 80) control patients was virtually devoid of TUNELpositive nuclei. In the prefrontal cortex of older (80-104 year-old) AD patients, TUNEL stain was also detected in the outer layers (II-IV), but most of the label was seenin layers V and VI. Both in the younger and the older AD cortices, only a small proportion of TUNEL-positive cells showed morphological signs of apoptosis, e.g. nuclear condensation. Quantitative assessment ofTUNEL-positive cells (Fig. 1) showed less than I cell per 700llm2 in the neocortex of younger control patients and about 3 cells per 700llm2 in older controls, the difference being small, but significant (p~0.05). The density ofTUNEL-positive cells in younger AD patients was significantly (p~0.05) increased, being 30 times higher than in age-matched control patients. The density of TUNEL-positive cells was even higher in older AD patients, i.e. more than 5 times that of younger AD patients and more than 20 times that of older control patients, both differences being statistically significant (p~0.05).
LDH immunoreaction
Very few cells in the prefrontal cortex were immunoreactive for LDR in younger controls, in older controls, in younger, and in older AD patients. Quantitative assessment showed on average about 10-14 cells per 700llm2 in all four patient groups, with no significant difference between the groups, indicating negligible hypoxia in the neocortex not only of younger and older control individuals, but also ofAD patients.
Silver impregnation
Bielschowski's silver stain revealed a dense network of dendritic trees and fine axons in the prefrontal cortex of younger ( Fig. 2a ) and older control individuals, but neither senile plaques nor neurofibrillary tangles. In contrast, fiber density was considerably diminished in the prefrontal cortex of younger AD patients, and many plaques and neurofibrillary tangles were detected (Fig. 2b) . In the neocortex of older AD patients, even fewer axons and dendrites were visible (Fig. 2c) . In order to quantify axon degeneration, sections were silver impregnated according to Guillery's modification of Nauta's silver stain (27) , a technique staining degenerating nerve fibers. Whereas relatively few degenerating fibers were detected in both younger and older control individuals, numerous nerve cell bodies were contacted by degenerating fiber terminals in the prefrontal cortex of both younger (Fig. 2d) and older AD patients. The density of neuronal somas contacted by these degenerating fibers was significantly (p~0.05) elevated by over 40% in the cortex ofolder control patients, compared to younger controls (Fig. 3 ). In the prefrontal cortex of AD patients, the density of nerve cell bodies contacted by degenerating fiber terminals was more than double that of age-matched control patients in the younger age group (p ::; 0.05) and was increased by 70% in older AD patients (p ::; 0.05) as compared to the respective control patients (Fig. 3) .
Hyperphosphorylated tau
In order to determine the relationship between DNA fragmentation and the expression of hyperphosphorylated tau, double staining forTUNEL and hyperphosphorylated tau was performed. Immunoreaction for hyperphosphorylated tau was virtually absent in the control cortices; only few of the younger and older control patients showed 
In younger AD, most TUNEL label is observed in cells devoid of tau immunoreaction (white arrows), but occasionally also in tau positive cells (white arrowhead). Numerous cells show hyperphosphorylated tau in the cytoplasm, but no TUNEL-positive nuclei (black arrows). In older AD patients (c), about 50% oftau-immunoreactive cells also show TUNEL-positive nuclei (arrowheads). x400.
tau label, and the number of positive cells was very small. In contrast, the prefrontal cortex of both younger (Fig. 4a, b) and older (Fig. 4c ) AD patients was densely packed with tau-positive cells. The numerical density of cells immunoreactive for hyperphosphorylated tau was 77 ± 0.7 cells per 700Jlm 2inADpatientsaged 58-79 years and 153± 1.6 cells per 700Jlm 2 in AD patients over 80 years of age ( Fig. Sa) , which was significantly higher (p~0.05). In younger AD patients, TUNEL stain was mainly observed in cells, which were not immunoreactive for hyperphosphorylated tau (Fig. 4a ) and most of the tau immunoreactive cells were devoid ofTUNEL reaction (Fig. 4b) . Only occasionally TUNELpositive cells were detected with additional tau label (Fig. 4b) . In older AD patients, most of the cells labeled for abnormal tau were also TUNELpositive ( Fig. 4c ) and TUNEL stain was rarely observed in cells, which were not immunoreactive for hyperphosphorylated tau. In order to quantify the relationship between hyperphosphorylated tau and DNA fragmentation, we determined the proportion of TUNEL-positive cells as a percentage of all taulabeled cells. Given the virtual absence of TUNELpositive cells in control cortices, this ratio was only determined in AD patients (Fig. 5b) . In younger AD patients, only about 4 % of the cells immunoreactive for hyperphosphorylated tau were also TUNELpositive. This proportion was markedly elevated in older AD patients. In their prefrontal cortex, 65% of the tau-positive cells also showed TUNEL stain, the difference between the two age groups being statistically significant (p~.05).
Both in the younger and in the older AD cortices, expression of hyperphosphorylated tau was frequently associated with immunoreactivity for activated caspase 3, but tau immunoreaction was also observed in cells devoid of activated caspase 3. No difference between the two age groups was apparent.
BDNF
All laminae of the prefrontal cortex showed BDNF immunoreactive cells, both in younger and 
NGF
Immunostaining for NGF appeared in the perikaryal cytoplasm of all 6 cortical layers of both younger and older control individuals as well as AD patients of both age groups. Frequently, label was also observed in the proximal dendrite of pyramidal cells. Numerical density of NGF-positive cells was the same in all patient groups examined (Fig. 6b) ; neither the differences between age groups nor the differences between AD and control individuals were significant.
DISCUSSION
The present study characterizes the differences between younger (58-79 year-old) and older (over 80) AD patients. In both AD age groups, signs of considerable neurodegeneration were observed, including a significant 30-150-fold increase in TUNEL-positive nuclei, loss of nerve fibers and elevated expression of hyperphosphorylated tau. However, the elevated TUNEL label, which was in the same order of magnitude as previously described in different neocortical and allocortical regions of AD brains (32) , is not accompanied by a similar increase in nuclear alterations suggestive of apoptotic cell death, e.g. formation of apoptotic bodies (8, 11, 33) . Although TUNEL stain does not necessarily predict apoptosis, and apoptotic neuronal death may actually be a rare event in AD (15) , it is generally accepted that positive TUNEL reaction is indicative of increased vulnerability to apoptotic stimuli (8, 11, 14, 18, 34) .
Significant differences were observed between younger and older AD patients: TUNEL-positive neurons were mainly observed in layers II-IV of younger, but in layers V and VI ofolderAD cortices. In addition, significantly more (about 5 times) TUNELpositive cells were detected in older AD individuals, indicating a more advanced pathological picture. In addition, a more prominent loss of nerve fibers was observed in older AD patients, accompanied by a much higher density of degenerated nerve fiber terminals and a significantly higher number of cells immunoreactive for hyperphosphorylated tau, a much higher proportion of which displayed TUNELpositive nuclei. Since TUNEL stain and apoptotic changes follow abnormal phosphorylation of tau (35) , this is additional evidence of a more advanced neuropathology in older AD individuals. Moreover, the MMSE scores in the older AD patients were below those of younger AD individuals. This more advanced clinical picture cannot be explained by a longer duration of the illness, because, in fact, clinical history was the same, if not shorter, in the group of older AD patients (5-9 years) compared to the younger AD age group (7-10 years). Our data therefore indicate that progression of the disease is faster in older AD individuals than in younger AD patients.
Further, we observed a significant reduction in BDNF-expressing neocortical cells of over 80year-old AD patients, whereas the density of BDNF immunoreactive cells in younger AD cortices was the same as that of controls. Decreased BDNF protein and mRNA levels in the AD neocortex, mainly at late stages of the disease, were detected by some authors, but not by others (18, 21) . Our observation that reduced density of BDNF positive cells is confined to AD patients over the age of 80 may explain these contradictory results.
It has been suggested that a differential cortical vulnerability to the degenerative process in very old AD patients is responsible for these differences in neuropathology (33) .Apossibleexplanationmaybe the "two-hit-model" of AD pathogenesis, which assumes that two independent insults are both necessary and sufficient to lead to AD (5) (6) . An initial insult, which may either be oxidative stress or abnormal mitotic signaling, induces an adaptive neuronal response, rather than cell death. These susceptible neurons, bearing mutations or being under stress, still function normally, but devote their compensatory potential to adapt to these stimuli. Thereby, they lose the capacity to respond adequately to other insults and become vulnerable. The cell-signaling molecules expressed in response to these "hits" are also key players in the activation of the apoptotic pathway (3, 5, 8) . The TUNEL-positive cells which appear in increasing number in AD may, at least partly, represent these vulnerable cells that have already been hit by the first insult. Only after a "second hit", e.g. trophic factor withdrawal, glucose deprivation, Ap toxicity or focal ischemia, does the disease process start. The onset of AD is thus a stochastic process that is age-related in penetrance (5) (6) : for a given neuron, the chances of being hit by such an insult increase with increasing age and consequently in older patients, more neurons are in the compensatory state and more vulnerable to a second hit. This not only implies that the onset ofAD is age-related, but also that the disease progresses faster in older patients, because of an increased proportion of vulnerable neurons. This may explain the more advanced neuropathological picture observed in AD patients over 80 years of age.
